Alfresa Corporation

13.42
0.00 (0.00%)
At close: Apr 24, 2025, 8:00 PM

Company Description

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally.

It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies.

The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies.

In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals.

Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities.

Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.

Alfresa Corporation
Alfresa  Corporation logo
Country JP
IPO Date Jan 3, 2018
Industry Medical - Distribution
Sector Healthcare
Employees 12,517
CEO Ryuji Arakawa

Contact Details

Address:
1-1-3 Otemachi
Tokyo,
JP
Website https://www.alfresa.com

Stock Details

Ticker Symbol ALFRY
Exchange PNK
Fiscal Year April - March
Reporting Currency USD
CIK Code n/a
CUSIP Number n/a
ISIN Number US0155091020
Employer ID -
SIC Code n/a

Key Executives

Name Position
Ryuji Arakawa Chief Executive Officer, President & Director
Kazuaki Hano Executive Officer
Miki Oguchi Executive Officer
Seiichi Kishida EVice President, Asst to the President of Gen Affairs, Corp Comm., dist, Qty mgmt., Compliance & Director
Shigeki Ohashi Managing Executive Officer, GM of Group Medical Wholesale Business Division & Director
Soichi Nemoto Executive Officer
Takashi Sasaki Executive Officer
Toshikazu Urakabe Executive Officer
Toshiki Tanaka Director & Managing Executive Officer
Yusuke Fukujin Executive Vice President & Representative Director

Latest SEC Filings

No SEC filings available.